MCCP
GILD icon

Mission Creek Capital Partners’s Gilead Sciences GILD Stock Holding History

Mission Creek Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Buy
2,542
+780
+44% +$103K 0.06% 181
2026
Q1 		$246K Sell
1,762
-70
-4% -$9.8K 0.05% 201
2025
Q4 		$225K Sell
1,832
-54
-3% -$6.56K 0.05% 198
2025
Q3 		$209K Hold
1,886
– – 0.04% 197
2025
Q2 		$209K Hold
1,886
– – 0.05% 192
2025
Q1 		$211K Sell
1,886
-1,159
-38% -$120K 0.05% 191
2024
Q4 		$281K Hold
3,045
– – 0.06% 201
2024
Q3 		$255K Sell
3,045
-267
-8% -$20.4K 0.06% 202
2024
Q2 		$227K Sell
3,312
-3,311
-50% -$221K 0.06% 194
2024
Q1 		$485K Sell
6,623
-5,659
-46% -$435K 0.13% 158
2023
Q4 		$995K Sell
12,282
-1,433
-10% -$112K 0.26% 110
2023
Q3 		$1.03M Sell
13,715
-240
-2% -$18.5K 0.35% 98
2023
Q2 		$1.08M Sell
13,955
-1,201
-8% -$95.8K 0.35% 97
2023
Q1 		$1.26M Sell
15,156
-53
-0.3% -$4.39K 0.43% 85
2022
Q4 		$1.31M Sell
15,209
-272
-2% -$21.5K 0.47% 77
2022
Q3 		$955K Sell
15,481
-175
-1% -$11K 0.36% 91
2022
Q2 		$968K Sell
15,656
-50
-0.3% -$3.1K 0.32% 102
2022
Q1 		$934K Sell
15,706
-1,001
-6% -$64K 0.25% 119
2021
Q4 		$1.21M Sell
16,707
-1,566
-9% -$108K 0.24% 115
2021
Q3 		$1.28M Sell
18,273
-470
-3% -$33K 0.24% 110
2021
Q2 		$1.29M Sell
18,743
-683
-4% -$45.6K 0.21% 97
2021
Q1 		$1.26M Sell
19,426
-263
-1% -$17K 0.19% 93
2020
Q4 		$1.15M Sell
19,689
-102
-0.5% -$6.16K 0.35% 87
2020
Q3 		$1.25M Buy
19,791
+11,858
+149% +$822K 0.49% 62
2020
Q2 		$610K Sell
7,933
-25
-0.3% -$1.92K 0.32% 85
2020
Q1 		$595K Sell
7,958
-70
-0.9% -$4.84K 0.32% 76
2019
Q4 		$522K Buy
+8,028
New +$523K 0.24% 109

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mission Creek Capital Partners's GILD Position: Q2 2026 in Review

Mission Creek Capital Partners increased its Gilead Sciences (GILD) stake by 44% in Q2 2026, buying an estimated $103K and bringing the position to 2,542 shares worth $321K. The position accounts for 0.06% of the portfolio, ranked #181.

Mission Creek Capital Partners first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.31M in Q4 2022. 2,287 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Mission Creek Capital Partners held 2,542 shares of Gilead Sciences worth $321K as of Q2 2026.
  • Mission Creek Capital Partners bought 780 Gilead Sciences shares in Q2 2026, an estimated $103K.
  • Gilead Sciences made up 0.06% of Mission Creek Capital Partners's portfolio in Q2 2026, its #181 holding.
  • Mission Creek Capital Partners first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • Mission Creek Capital Partners's Gilead Sciences position peaked at $1.31M in Q4 2022.
  • 2,287 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Mission Creek Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.